Smooth muscle tumors of the gastrointestinal tract: a clinico - pathologic analysis of 159 cases

彭俊生,王吉甫,王颀,周慕衍,宋新明,余成仿
DOI: https://doi.org/10.3760/cma.j.issn.1007-631X.1998.06.110
1998-01-01
Abstract:Objective:To investigate the clinico-pathologic behavior of smooth muscle tumors (SMT) of the gastrointestinal tract.Methods:The clinical course and pathologic features were analyzed for 159 SMT patients. The number of mitoses seen in 50 high-power fields(HPF) was assessed for each tumor.Results:In this series, 53 cases were of leiomyoma, 3 of epithelioid leiomyoma, and 103 of leiomyosarcoma. 49.7%(79) were in the stomach, 26.4%(42) in the small bowel, 11.3%(18) in the rectum, 6.3%(10) in the duodenum and the colon each. The most common presenting symptoms and signs were abdominal pain, gastrointestinal bleeding, and abdominal mass. 84.4% of the tumors were diagnosed preoperatively by combining gastrointestinal endoscopy and barium meal or enema examination. Leiomyoma, including epithelioid leiomyoma, had 0.31±0.15 mitoses/10HPF, and leiomyosarcoma had 5.77±2.30 mitoses/10HPF(P<0.001). Furthermore, in cases of leiomyosarcoma, tumors presenting with liver metastases and/or recurrence had 7.85±2.65 mitoses/10HPF, while those without had 3.44±1.62 mitoses/10HPF(P<0.001).Conclusion:SMT of the gastrointestinal tract often occurred in the stomach and the small bowel. Mitotic index is an important criterion to distinguish the benign SMT from malignant. The higher the frequency of mitoses, the worse the prognosis may be.
What problem does this paper attempt to address?